Clinical Trials Update: July 6, 2006
Premature Ejaculation Colorectal Cancer Multiple Sclerosis
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
If you find it difficult to control ejaculation during sex, you may wish to participate in this 9-week clinical research study evaluating the safety and effectiveness of an investigational medication. You may qualify if you are 18-55 and regularly experience premature ejaculation, in a stable relationship with one woman for at least six months, and in general good health. The research site is in Raleigh, N.C.
The study will evaluate the effectiveness of adding Panitumimab in treating metastatic colorectal cancer versus using only Oxaliplatin, Leucovorin, 5FU and Bevacizumab. Candidates who have cancer of the colon or rectum that has spread to other parts of the body and have not had prior treatment for metastatic colorectal cancer may be eligible. The research site is in Gainesville, Fla.
This is a 3-to-4-month study to see if people with MS can tolerate a specific exercise program and if the program improves their ability to stand and walk. The study involves 3-5 one-hour sessions per week for 36 sessions. Volunteers 18-55 who have been diagnosed with primary or secondary progressive MS and have difficulty walking may be included. Patients are not eligible for the study if they have a history of fracture in the legs, or are unable to have an MRI scan. The research site is in Los Angeles, Calif.
Copyright 2006 Thomson CenterWatch. All rights reserved.